Nautilus Biotechnology Inc.: Jefferies assumes the insured amount is a position and buy rating; target share price is $3 to $5

Nautilus Biotechnology Inc.: Jefferies assumes the insured amount is a position and buy rating; target share price is $3 to $5

Zhitong FinanceJun 3 01:11

Express News | Nautilus Biotechnology Inc : Jefferies Assumes Coverage With Hold Vs Buy Rating; Price Target $3 Vs $5

BreakingsJun 3 01:10

Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

SEATTLE, May 23, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule protein analysis platform, today announced the company wi

Nautilus BiotechnologyMay 22 23:00

Nautilus Biotechnology's ESG Challenge: Navigating the Rising Tide of Corporate Responsibility Standards

TipRanksMay 2 01:02

Nautilus Biotechnology Inc (NAUT) Q1 2024 Earnings Call Transcript Highlights: A Detailed ...

Yahoo FinanceMay 1 02:08

Earnings Call Summary | Nautilus Biotechnology(NAUT.US) Q1 2024 Earnings Conference

The following is a summary of the Nautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings Call Transcript:Financial Performance:Nautilus Biotechnology reported Q1 2024 total operating expenses of $21.6 m

Futu NewsApr 30 14:40 · Conference Call